title: [Utility of morphogenetic protein for the treatment of congenital pseudoarthrosis of the tibia].
abstract: OBJECTIVE
  To report the ability of bone morphogenetic protein to achieve bone healing in patients with congenital pseudoarthrosis of the tibia.
  
  
  METHODS
  Three patients with a diagnosis of congenital pseudoarthrosis of the tibia were followed-up for six months. Bone healing and functional capacity of the limb were observed.
  
  
  RESULTS
  Bone healing occurred in all cases at a mean of three and half months of treatment.
  
  
  CONCLUSIONS
  Morphogenetic protein is useful as an adjuvant to achieve bone regeneration and healing in patients with congenital pseudoarthrosis of the tibia.
authors.forename: C R
authors.initials: CR
authors.lastname: Soria-Sánchez
authors.forename: A
authors.initials: A
authors.lastname: López-Durán
authors.forename: A
authors.initials: A
authors.lastname: Isunza-Ramirez
mesh_terms: D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage*; D001861:Bone Regeneration / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011542:Pseudarthrosis / Q000151:congenital* / Q000473:pathology / Q000628:therapy; D013977:Tibia / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D019485:Bone Morphogenetic Proteins